Application 212995
- Type
- ANDA
- Sponsor
- PIRAMAL HLTHCARE UK
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 90MG | No | No |
| 002 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 360MG | No | No |
| 003 | DEFERASIROX | DEFERASIROX | TABLET;ORAL | 180MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 70700-269 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-269 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-269 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-269 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-269 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-270 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-270 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-270 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-271 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-271 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-271 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-271 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |
| 70700-271 | Deferasirox | Deferasirox | Xiromed, LLC | ANDA | Current |